PLCL2
Inactive phospholipase C-like protein 2
Also known as: KIAA1092, PLCE2, PLCL2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UPR0
- Gene
- PLCL2
- Ensembl
- ENSG00000154822
- Chromosome
- 3
- Canonical length
- 1127 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables GABA receptor binding activity. Predicted to be involved in several processes, including gamma-aminobutyric acid signaling pathway; negative regulation of cold-induced thermogenesis; and phosphatidylinositol-mediated signaling. Predicted to act upstream of or within B cell proliferation involved in immune response; B-1a B cell differentiation; and negative regulation of B cell receptor signaling pathway. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1127 residues, UniProt reviewed canonical sequence.
>Q9UPR0|PLCL2
1 MAECGRGGAA GGALPTSPGP ALGAKGALKA GVGEGGGGGG RLGHGRARYD SGGVSNGDCS
61 LGVSGDEARA SPTRGPRGVA LAPTPSAVVC TLPRESKPGG LPRRSSIIKD GTKQKRERKK
121 TVSFSSMPTE KKISSASDCI NSMVEGSELK KVRSNSRIYH RYFLLDADMQ SLRWEPSKKD
181 SEKAKIDIKS IKEVRTGKNT DIFRSNGISD QISEDCAFSV IYGENYESLD LVANSADVAN
241 IWVTGLRYLI SYGKHTLDML ESSQDNMRTS WVSQMFSEID VDNLGHITLC NAVQCIRNLN
301 PGLKTSKIEL KFKELHKSKD KAGTEVTKEE FIEVFHELCT RPEIYFLLVQ FSSNKEFLDT
361 KDLMMFLEAE QGVAHINEEI SLEIIHKYEP SKEGQEKGWL SIDGFTNYLM SPDCYIFDPE
421 HKKVCQDMKQ PLSHYFINSS HNTYLIEDQF RGPSDITGYI RALKMGCRSV ELDVWDGPDN
481 EPVIYTGHTM TSQIVFRSVI DIINKYAFFA SEYPLILCLE NHCSIKQQKV MVQHMKKLLG
541 DKLYTTSPNV EESYLPSPDV LKGKILIKAK KLSSNCSGVE GDVTDEDEGA EMSQRMGKEN
601 MEQPNNVPVK RFQLCKELSE LVSICKSVQF KEFQVSFQVQ KYWEVCSFNE VLASKYANEN
661 PGDFVNYNKR FLARVFPSPM RIDSSNMNPQ DFWKCGCQIV AMNFQTPGLM MDLNIGWFRQ
721 NGNCGYVLRP AIMREEVSFF SANTKDSVPG VSPQLLHIKI ISGQNFPKPK GSGAKGDVVD
781 PYVYVEIHGI PADCAEQRTK TVHQNGDAPI FDESFEFQIN LPELAMVRFV VLDDDYIGDE
841 FIGQYTIPFE CLQTGYRHVP LQSLTGEVLA HASLFVHVAI TNRRGGGKPH KRGLSVRKGK
901 KSREYASLRT LWIKTVDEVF KNAQPPIRDA TDLRENMQNA VVSFKELCGL SSVANLMQCM
961 LAVSPRFLGP DNTPLVVLNL SEQYPTMELQ GIVPEVLKKI VTTYDMMIQS LKALIENADA
1021 VYEKIVHCQK AAMEFHEHLH SIGTKEGLKE RKLQKAVESF TWNITILKGQ ADLLKYAKNE
1081 TLENLKQIHF AAVSCGLNKP GTENADVQKP RRSLEVIPEK ANDETGELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLCL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 26 nTPM
- heart muscle: 20 nTPM
- cerebellum: 18 nTPM
- spleen: 12 nTPM
- adrenal gland: 11 nTPM
- ovary: 11 nTPM
Single-cell type
- microglia: 495 nCPM
- renal collecting duct principal cells: 369 nCPM
- renal collecting duct intercalated cells: 317 nCPM
- brain inhibitory neurons: 287 nCPM
- brain excitatory neurons: 255 nCPM
- proximal tubule cells: 153 nCPM
Immune cell
- NK-cell: 6.5 nTPM
- memory CD8 T-cell: 2.9 nTPM
- MAIT T-cell: 2.6 nTPM
- gdT-cell: 2.1 nTPM
- naive CD8 T-cell: 2.1 nTPM
- memory CD4 T-cell: 2 nTPM
Brain region
- cerebellum: 33 nTPM
- basal ganglia: 15 nTPM
- pons: 13 nTPM
- cerebral cortex: 13 nTPM
- white matter: 11 nTPM
- hippocampal formation: 9.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.09
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.33
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell proliferation involved in immune response
- B-1a B cell differentiation
- gamma-aminobutyric acid signaling pathway
- negative regulation of B cell receptor signaling pathway
- negative regulation of cold-induced thermogenesis
- phosphatidylinositol metabolic process
- phosphatidylinositol-mediated signaling
- regulation of synaptic transmission, GABAergic
- release of sequestered calcium ion into cytosol
Molecular functions
- GABA receptor binding
- inositol 1,4,5 trisphosphate binding
- phosphatidylinositol-4,5-bisphosphate phospholipase C activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Phosphatidylinositol-specific phospholipase C, X domain
- Phosphoinositide phospholipase C family
- Phospholipase C, phosphatidylinositol-specific, Y domain
- Pleckstrin homology domain
- EF-hand domain pair
- PH-like domain superfamily
- Phosphoinositide-specific phospholipase C, EF-hand-like domain
- PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily
- C2 domain superfamily
- C2 domain
- Phosphatidylinositol-specific phospholipase C, Y domain
- Phosphatidylinositol-specific phospholipase C, X domain
- Phosphoinositide-specific phospholipase C, efhand-like
- Pleckstrin homology domain
- Inactive phospholipase C-like protein 2, EF-hand domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLCL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLCL2 as an antibody target. Whether an autoantibody or antibody against PLCL2 could matter depends on whether native PLCL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLCL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLCL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...